Related Experiment Video
Updated: Jun 26, 2026
09:07
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
9.8K
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for
M Chelsea Lane1, Catherine J Luke1, Joseph Bresee2
1Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Influenza and Other Respiratory Viruses
|October 23, 2024
Summary
Controlled human influenza virus infection model (CHIVIM) studies offer valuable insights into influenza infection and immune response. While useful for vaccine development, CHIVIM studies should be cautiously applied and do not replace field efficacy trials.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Controlled human influenza virus infection model (CHIVIM) studies are crucial for understanding influenza.
- Recent advancements and applications of CHIVIM studies were reviewed.
- Collaboration is key to advancing CHIVIM research.
Purpose of the Study:
- To review the current research landscape of CHIVIM studies.
- To identify actionable next steps for CHIVIM research and application.
- To discuss the utility of CHIVIM in vaccine development and regulatory considerations.
Main Methods:
- A meeting convened by NIAID and partners, including Flu Lab, CIHR, and CDC.
- Presentations and panel discussions covered CHIVIM use cases, ethics, innovations, and standardization.
- A summary of key takeaways and future directions was generated.
Main Results:
- CHIVIM studies are valuable for studying influenza infection, immune response, and transmission.
- CHIVIMs can aid in developing vaccines and medical countermeasures but require a cautious approach for de-risking clinical development.
- CHIVIM data supports vaccine licensure but does not replace field efficacy trials.
Conclusions:
- CHIVIM studies offer significant potential for influenza research and vaccine development.
- Standardization, expanded capacity, and innovative approaches are needed for future CHIVIM studies.
- Continued collaboration among stakeholders is essential for advancing CHIVIM applications.
Related Concept Videos
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...